Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases.
about
Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal CancerTargeting RTK Signaling Pathways in CancerConcomitant tumor expression of EGFR and TATI/SPINK1 associates with better prognosis in colorectal cancer.Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR statusImmunophenotype and molecular characterisation of adenocarcinoma of the small intestine.Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal CancerGenetic and immune factors underlying the efficacy of cetuximab and panitumumab in the treatment of patients with metastatic colorectal cancer.Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinoma.Alteration of EGFR spatiotemporal dynamics suppresses signal transduction.Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.HGF rescues colorectal cancer cells from EGFR inhibition via MET activationEGFR Signaling in Colorectal Carcinoma.Dual EGFR inhibition in combination with anti-VEGF treatment in colorectal cancerIdentify lymphatic metastasis-associated genes in mouse hepatocarcinoma cell lines using gene chipThe prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer.Epidermal growth factor receptor mutations in colorectal cancer patientsA review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferationAngiogenesis, immune system and growth factors: new targets in colorectal cancer therapy.SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression.Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer.Antibody-nanoparticle conjugates to enhance the sensitivity of ELISA-based detection methodsTargeting the epidermal growth factor receptor in colorectal cancer: advances and controversies.Antitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer CellsA simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.Recent developments in colorectal cancer treatment by monoclonal antibodies.Mechanisms of resistance to EGFR targeted therapies.Id-1: regulator of EGFR and VEGF and potential target for colorectal cancer therapy.Pharmacogenomics in colorectal cancer: the first step for individualized-therapyDevelopments in epidermal growth factor receptor-targeting therapy for solid tumors: focus on matuzumab (EMD 72000).Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system.Predictive and prognostic markers in colorectal cancer.Implications of EGFR PharmDx kit for cetuximab eligibility.Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant.Frequent mutations of the CA simple sequence repeat in intron 1 of EGFR in mismatch repair-deficient colorectal cancers.An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expressionGefitinib and celecoxib in advanced metastatic gastrointestinal tumors: a pilot feasibility study.The expression of multiple proteins as prognostic factors in colorectal cancer: cathepsin D, p53, COX-2, epidermal growth factor receptor, C-erbB-2, and Ki-67Expression and clinical value of EGFR in human meningiomas.Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers.
P2860
Q26748924-06496260-1CFE-4961-84D9-38331B338413Q26781278-8A347FB7-3FD2-4E8B-AF02-2E45A5608551Q31143290-5BE6C2A6-BFBB-43FD-957B-8DE630CF3CB7Q33620091-EB85EA5E-47FF-4E63-9D6C-E33BFF1C466EQ33620113-00CDE350-CE3E-45A1-83E2-A125CD917DB2Q33624491-21271903-FBE7-41CC-88DA-C63CAA224218Q33683680-A2E38B05-1BB1-412C-95D8-F2FCFF1061DBQ34017423-EF256F5B-024B-4266-BAFB-9B6E63D8761FQ34326437-82E6A177-9763-49CB-80A5-F158567CFBDFQ34465146-C18B73E0-D693-4E7E-9410-F5A9DAA775A1Q34550898-1A17F1FF-7FDC-435B-ABD7-7EDBF20C11BBQ34627605-C944E1FB-233F-4B5D-9C87-38376EF0D6D6Q34781374-6C78B7BC-E0AD-48B7-8C40-87280FCE2FE6Q35010418-B3A34832-5FCD-4429-973D-B71DBC38D57DQ35065408-627985BA-4CB9-4F39-A202-B8CAD5EF9DECQ35134625-FB2728F3-895A-48AE-BC48-296DD19384C3Q35584153-12389FBF-C465-4BC4-AEA6-086BBE7B71FBQ35994001-E9E049B3-537B-4C60-8869-0FED6B359F1AQ36235571-E44BB3D5-1FC9-41F2-B2E8-E9552838CA63Q36245896-CCEF35B4-BD83-4545-AAA6-E44B0B6FA5DBQ36249234-D4E67886-35E4-44A0-85A3-B9A2E67DFC0DQ36369268-F1078A30-956D-4DB0-87C5-73F44F266506Q36468876-D3E88166-125E-4FD8-A592-C9A32FE14FCAQ36482500-F93BC26A-BD3E-41EE-A5F3-9DB484083417Q36609946-46339C6F-92E9-48DF-A80C-683B04B3D8C7Q36627254-4C27583F-C2C9-4FE4-953A-7181837CD60EQ36887721-FEA83231-CECC-40EE-AACE-E9911E2E750AQ36986849-AAE336B8-A49F-44C5-AFCA-4303435EE05CQ36996329-7C2BE69B-BF40-47C7-BBF2-04924DAC38D1Q37052752-61E5B5EC-97C7-4A51-89A8-139C12CAC2C2Q37059520-E91D144C-A896-40ED-999C-4D99DA92E379Q37073444-41BC2427-7830-4B53-A9A8-11D916FE54DBQ37118974-E2E190E5-EA75-4A67-AD42-83F8F2B85D4AQ37160656-0AB023FF-4B7A-4FD9-9A0A-0C09E2551734Q37209926-D9C8E463-32B6-4639-8379-60B54FC0F1FDQ37448192-41132C56-F027-48A6-A10C-D067CACB8210Q37522211-1D5D8EEA-B9AE-4684-A54F-9E2FFBD7E4A1Q37564008-C23730B8-A90B-4D56-AE7F-8CC025EBF616Q37732068-332C126D-F5E8-4C05-A2C1-81ECF1F6ADB5Q38073827-4084CF1F-01EE-4841-837D-00717DDF044D
P2860
Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Evaluation of the epidermal gr ...... urs and lymph node metastases.
@ast
Evaluation of the epidermal gr ...... urs and lymph node metastases.
@en
Evaluation of the epidermal growth factor receptor
@nl
type
label
Evaluation of the epidermal gr ...... urs and lymph node metastases.
@ast
Evaluation of the epidermal gr ...... urs and lymph node metastases.
@en
Evaluation of the epidermal growth factor receptor
@nl
prefLabel
Evaluation of the epidermal gr ...... urs and lymph node metastases.
@ast
Evaluation of the epidermal gr ...... urs and lymph node metastases.
@en
Evaluation of the epidermal growth factor receptor
@nl
P2093
P1476
Evaluation of the epidermal gr ...... urs and lymph node metastases.
@en
P2093
P304
P356
10.1016/S0959-8049(02)00234-4
P577
2002-11-01T00:00:00Z